The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Osteopontin: regulation in tumor metastasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
The American Journal of Physiology
(1899) · The American Naturalist · doi:10.1086/277182 · Cited by 5,654
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W. H., Beddington, R. S. P., Mundlos, S., Olsen, B. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80259-7 · Cited by 2,814
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Role of angiogenesis in tumor growth and metastasis
FOLKMAN, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,400
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
(1956) · Observations on the Alewife, Pomolobus Pseudoharengus (Wilson), in Fresh Wate · doi:10.3138/9781487596026-005 · Cited by 1,534
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Osteopontin: a protein with diverse functions
Denhardt, D. T., & Guo, X. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.8262332 · Cited by 1,078
Oldberg, A., Franzén, A., & Heinegård, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8819 · Cited by 1,078
Denhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
Sodek, J., Ganss, B., & McKee, M. D. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110030101 · Cited by 993
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Lee, K.-S., Kim, H.-J., Li, Q.-L., Chi, X.-Z., Ueta, C., Komori, T., Wozney, J. M., Kim, E.-G., Choi, J.-Y., Ryoo, H.-M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8783-8792.2000 · Cited by 865
Osteopontin--a possible anchor of osteoclasts to bone.
Reinholt, F. P., Hultenby, K., Oldberg, A., & Heinegård, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4473 · Cited by 824
Regulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
Proceedings of the American Association for Cancer Research.
Konings, E. J. M., van den Brandt, P. A., Saris, W. H. M., Brants, H. A. M., & Goldbohm, R. A. (2001) · Cited by 764
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun
Chiu, R., Angel, P., & Karin, M. (1989) · Cell · doi:10.1016/0092-8674(89)90754-x · Cited by 688
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
A natural classification of the basic helix–loop–helix class of transcription factors
Atchley, W. R., & Fitch, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5172 · Cited by 668
Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergiou, A., Peruzzi, C. A., & Detmar, M. J. (1996) · Europe PMC (PubMed Central) · Cited by 626
Schönthal, A., Herrlich, P., Rahmsdorf, H. J., & Ponta, H. (1988) · Cell · doi:10.1016/0092-8674(88)90195-x · Cited by 579
Stamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
Core-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569
Isolation and characterization of two sialoproteins present only in bone calcified matrix
Franzén, A., & Heinegård, D. (1985) · Biochemical Journal · doi:10.1042/bj2320715 · Cited by 559
Liaw, L., Skinner, M. P., Raines, E. W., Ross, R., Cheresh, D. A., Schwartz, S. M., & Giachelli, C. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117718 · Cited by 512
Sp transcription factor family and its role in cancer
Safe, S., & Abdelrahim, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.006 · Cited by 500
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Noda, M., Vogel, R. L., Craig, A. M., Prahl, J., DeLuca, H. F., & Denhardt, D. T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9995 · Cited by 464
Molecular aspects of tumor cell invasion and metastasis
Aznavoorian, S., Murphy, A. N., Stetler-Stevenson, W. G., & Liotta, L. A. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1368::aid-cncr2820710432>3.0.co;2-l · Cited by 459
Significance of CD44 gene products for cancer diagnosis and disease evaluation
Matsumura, Y., & Tarin, D. (1992) · The Lancet · doi:10.1016/0140-6736(92)93077-z · Cited by 450
Interaction and Functional Cooperation of PEBP2/CBF with Smads
Hanai, J.-I., Chen, L. F., Kanno, T., Ohtani-Fujita, N., Kim, W. Y., Guo, W.-H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M.-J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31577 · Cited by 449
Fisher, L. W., Hawkins, G. R., Tuross, N., & Termine, J. D. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47991-4 · Cited by 441
Osteopontin expression and function: Role in bone remodeling
Denhardt, D. T., & Noda, M. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<92::aid-jcb13>3.0.co;2-a · Cited by 440
Agrawal, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.513 · Cited by 413
Liaw, L., Almeida, M., Hart, C. E., Schwartz, S. M., & Giachelli, C. M. (1994) · Circulation Research · doi:10.1161/01.res.74.2.214 · Cited by 393
Shiraga, H., Min, W., VanDusen, W. J., Clayman, M. D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., & Neilson, E. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.426 · Cited by 390
Proteolysis and cell migration: creating a path?
Murphy, G., & Gavrilovic, J. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00022-8 · Cited by 384
Young, M. R., Li, J.-J., Rincón, M., Flavell, R. A., Sathyanarayana, B. K., Hunziker, R., & Colburn, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9827 · Cited by 382
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
Fedarko, N. S., Jain, A., Karadağ, A., Eman, M. R. V., & Fisher, L. W. (2001) · PubMed · Cited by 380
Young, M. F., Kerr, J. M., Termine, J. D., Wewer, U. M., Wang, M. G., McBride, O. W., & Fisher, L. W. (1990) · Genomics · doi:10.1016/0888-7543(90)90191-v · Cited by 365
Katagiri, Y. U., Sleeman, J. P., Fujii, H., Herrlich, P., Hotta, H., Tanaka, K., Chikuma, S., Yagita∥, H., Okumura, K., Murakami, M., et al. (1999) · PubMed · Cited by 363
Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation
O'Regan, A., & Berman, J. S. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00163.x · Cited by 357
Osteoblasts are target cells for transformation in c-fos transgenic mice
Grigoriadis, A., Schellander, K., Wang, Z., & Wagner, E. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.685 · Cited by 350
Osteopontin expression and distribution in human carcinomas.
Brown, L. F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E. J., Tognazzi, K., Perruzzi, C. A., Dvorak, H. F., & Senger, D. R. (1994) · PubMed Central · Cited by 329
Deng, T., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.3.479 · Cited by 328
RUNX transcription factors as key targets of TGF-β superfamily signaling
Ito, Y., & Miyazono, K. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00007-8 · Cited by 324
Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kozak, C. A., Mock, B. A., & Morse, H. C. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.1.145 · Cited by 322
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1
Jochum, W., David, J.-P., Elliott, C., Wutz, A., Plenk, H., Matsuo, K., & Wagner, E. F. (2000) · Nature Medicine · doi:10.1038/79676 · Cited by 311
Yokosaki, Y., Matsuura, N., Sasaki, T., Murakami, I., Schneider, H., Higashiyama, S., Saitoh, Y., Yamakido, M., Taooka, Y., & Sheppard, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36328 · Cited by 305
Vargas-Roig, L. M., Gago, F. E., Tello, O. M., Aznar, J. C., & Ciocca, D. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981023)79:5<502::aid-ijc10>3.0.co;2-3 · Cited by 302
Transformed mammalian cells secrete specific proteins and phosphoproteins
Senger, D. R., Wirth, D. F., & Hynes, R. O. (1979) · Cell · doi:10.1016/0092-8674(79)90103-x · Cited by 298
Sato, H., Kita, M., & Seiki, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49485-4 · Cited by 291
The metastasis gene osteopontin: a candidate target for cancer therapy
Weber, G. F. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00037-3 · Cited by 286
Engleman, V. W., Nickols, G. A., Ross, F. P., Horton, M. A., Griggs, D. W., Settle, S. L., Ruminski, P. G., & Teitelbaum, S. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119404 · Cited by 285
Singhal, H., Bautista, D., Tonkin, K. S., O’Malley, F. P., Tuck, A. B., Chambers, A. F., & Harris, J. F. (1997) · PubMed · Cited by 285
Zohar, R., Suzuki, N., Suzuki, K., Arora, P., Glogauer, M., McCulloch, C. A. G., & Sodek, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<118::aid-jcp13>3.0.co;2-y · Cited by 276
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., El‐Tanani, M., Rudland, S. D. S., Barraclough, R., Winstanley, J. H. R., Howitt, R., & West, C. R. (2002) · PubMed · Cited by 276
Bayless, K. J., Salazar, R., & Davis, G. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65038-9 · Cited by 273
Expression of CD44R1 adhesion molecule in colon carcinomas and metastases
Tanabe, K. K., Ellis, L. M., & Saya, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90490-8 · Cited by 271
Sato, M., Morii, E., Komori, T., Kawahata, H., Sugimoto, M., Terai, K., Shimizu, H., Yasui, T., Ogihara, H., Yasui, N., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202064 · Cited by 270
Osteopontin: possible role in prostate cancer progression.
Thalmann, G. N., Sikes, R. A., Devoll, R. E., Kiefer, J., Markwalder, R. V., Klima, I., Farach‐Carson, M. C., Studer, U. E., & Chung, L. W. K. (1999) · PubMed · Cited by 261
A Biochemical Characterization of the Binding of Osteopontin to Integrins αvβ1 and αvβ5
Hu, D. D., Lin, E. C. K., Kovach, N. L., Hoyer, J. R., & Smith, J. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26232 · Cited by 254
P700: the primary electron donor of photosystem I
Webber, A. N., & Lubitz, W. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00198-0 · Cited by 251
Pan, H., Ou, Y., Peng, S., Liu, S., Lai, P., Lee, P., Sheu, J., Chen, C., & Hsu, H. (2003) · Cancer · doi:10.1002/cncr.11487 · Cited by 251
Philip, S., Bulbule, A., & Kundu, G. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103334200 · Cited by 247
Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin
Smith, L. L., Cheung, H.-K., Ling, L. E., Chen, J., Sheppard, D., Pytela, R., & Giachelli, C. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28485 · Cited by 247
Lin, Y.-H., & Yang-Yen, H.-F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105132200 · Cited by 246
Bellahcène, A., & CASTRONOVO, V. (1995) · Europe PMC (PubMed Central) · Cited by 240
Philip, S., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207309200 · Cited by 240
Hanrahan, V., Currie, M. J., Gunningham, S. P., Morrin, H. R., Scott, P. A., Robinson, B. A., & Fox, S. B. (2003) · The Journal of Pathology · doi:10.1002/path.1339 · Cited by 234
Patarca, R., Saavedra, R. A., & Cantor, H. (1993) · PubMed · Cited by 226
Singh, R. P., Patarca, R., Schwartz, J., Singh, P., & Cantor, H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.1931 · Cited by 226
Fedarko, N. S., Jain, A., Karadag, A., & Fisher, L. W. (2004) · The FASEB Journal · doi:10.1096/fj.03-0966fje · Cited by 220
Osteopontin is a ligand for the α4β1 integrin
Bayless, K. J., Meininger, G. A., Scholtz, J. M., & Davis, G. E. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.9.1165 · Cited by 214
Barnes, G. B., Javed, A., Waller, S. M., Kamal, M. H., Hebert, K. E., Hassan, M. Q., Bellahcène, A., van Wijnen, A. J., Young, M. F., Lian, J. B., et al. (2003) · PubMed · Cited by 211
Osteocyte function, osteocyte death and bone fracture resistance
Noble, B. S., & Reeve, J. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00174-4 · Cited by 210
Senger, D. R., Perruzzi, C. A., Papadopoulos-Sergiou, A., & Van de Water, L. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.5.565 · Cited by 208
Coffman, J. A. (2003) · Cell Biology International · doi:10.1016/s1065-6995(03)00018-0 · Cited by 204
Noda, M., Yoon, K., Prince, C. W., Butler, W. T., & Rodan, G. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68331-0 · Cited by 202
Senger, D. R., Perruzzi, C. A., Gracey, C. F., Papadopoulos, A., & Tenen, D. G. (1988) · PubMed · Cited by 200
Tuck, A. B., Arsenault, D., O’Malley, F. P., Hota, C., Ling, M. C., Wilson, S. M., & Chambers, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202799 · Cited by 191
Osteopontin expression in lung cancer
Chambers, A. F., Wilson, S. M., Kerkvliet, N., O'Malley, F. P., Harris, J. F., & Casson, A. G. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00595-1 · Cited by 189
Integrin αvβ3 Expression by Bone-residing Breast Cancer Metastases
Liapis, H., Flath, A., & Kitazawa, S. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199606000-00008 · Cited by 186
Wang, Z. Q., Grigoriadis, A. E., Möhle-Steinlein, U., & Wagner, E. F. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07783.x · Cited by 176
Hwang, S. M., Lopez, C. A., Heck, D. E., Gardner, C. R., Laskin, D. L., Laskin, J. D., & Denhardt, D. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42407-0 · Cited by 176
Denda, S., Reichardt, L. F., & Müller, U. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.6.1425 · Cited by 176
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404674200 · Cited by 175
The role of p53-target genes in human cancer
Tokino, T., & Nakamura, Y. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00051-7 · Cited by 174
Singh, K., Balligand, J.-L., Fischer, T. A., Smith, T. W., & Kelly, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28471 · Cited by 172
Crawford, H. C., Matrisian, L. M., & Liaw, L. (1998) · PubMed · Cited by 169
Craig, A. M., & Denhardt, D. T. (1991) · Gene · doi:10.1016/0378-1119(91)90362-f · Cited by 168
Transforming growth factor-β signaling in normal and malignant hematopoiesis
Kim, S.-J., & Letterio, J. (2003) · Leukemia · doi:10.1038/sj.leu.2403069 · Cited by 166
Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer
Bramwell, V. H. C., Doig, G. S., Tuck, A. B., Wilson, S. M., Tonkin, K. S., Tomiak, A., Perera, F., Vandenberg, T. A., & Chambers, A. F. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2354 · Cited by 165
Liaw, L., Lindner, V., Schwartz, S. M., Chambers, A. F., & Giachelli, C. M. (1995) · Circulation Research · doi:10.1161/01.res.77.4.665 · Cited by 163
Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice
Sirito, M., Lin, Q., Deng, J. M., Behringer, R. R., & Sawadogo, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3758 · Cited by 161
Das, R., Mahabeleshwar, G. H., & Kundu, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303445200 · Cited by 158
Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin
Senger, D. R., & Perruzzi, C. A. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00067-5 · Cited by 156
Inman, C. K., & Shore, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308001200 · Cited by 155
Oates, A. J., Barraclough, R., & Ps, R. (1996) · PubMed · Cited by 149
Overexpression of osteopontin in hepatocellular carcinoma
Gotoh, M., Sakamoto, M., Kanetaka, K., Chuuma, M., & Hirohashi, S. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01316.x · Cited by 148
The cDNA and derived amino acid sequence for human osteopontin
Kiefer, M. C., Bauer, D. M., & Barr, P. J. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.8.3306 · Cited by 148
Tuck, A. B., Elliott, B. E., Hota, C., Tremblay, E., & Chambers, A. F. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000901)78:3<465::aid-jcb11>3.0.co;2-c · Cited by 145
Transforming Growth Factor-Beta in Osteolytic Breast Cancer Bone Metastases
Guise, T. A., & Chirgwin, J. M. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093055.96273.69 · Cited by 144
Nakamura, Y., Yasuoka, H., Tsujimoto, M., Yang, Q., Imabun, S., Nakahara, M., Nakao, K., Nakamura, M., Mori, I., & Kakudo, K. (2003) · PubMed · Cited by 142
RUNX: A trilogy of cancer genes
Lund, A. H., & van Lohuizen, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00049-1 · Cited by 140
Osteopontin Is a Negative Feedback Regulator of Nitric Oxide Synthesis in Murine Macrophages
Guo, H., Cai, C. Q., Schroeder, R. A., & Kuo, P. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1079 · Cited by 139
Self-citationOsteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages
Rollo, E. E., Laskin, D. L., & Denhardt, D. T. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.3.397 · Cited by 135
Cloning and characterization of the human osteopontin gene and its promoter
Hijiya, N., Setoguchi, M., Matsuura, K., Higuchi, Y., Akizuki, S., & Yamamoto, S. (1994) · Biochemical Journal · doi:10.1042/bj3030255 · Cited by 133
Hruska, K. A., ROLNICK, F., Huskey, M., Alvarez, U., & Cheresh, D. A. (1995) · Endocrinology · doi:10.1210/endo.136.7.7540546 · Cited by 129
Osteopontin-Stimulated Vascular Smooth Muscle Cell Migration Is Mediated by β3 Integrin
Yue, T.-L., McKenna, P., Ohlstein, E. H., et al. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1282 · Cited by 129
Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma
Shijubo, N., UEDE, T., KON, S., MAEDA, M., SEGAWA, T., Imada, A., HIRASAWA, M., & ABE, S. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9807094 · Cited by 128
Smith, J. H., & Denhardt, D. T. (1987) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240340103 · Cited by 128
Tuck, A. B., Hota, C., Wilson, S. M., & Chambers, A. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206209 · Cited by 128
p53 induces TAP1 and enhances the transport of MHC class I peptides
Zhu, K., Wang, J., Zhu, J., Jiang, J., Shou, J., & Chen, X. (1999) · Oncogene · doi:10.1038/sj.onc.1203235 · Cited by 127
Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Leali, D., Dell’Era, P., Stabile, H., Sennino, B., Chambers, A. F., Naldini, A., Sozzani, S., Nico, B., Ribatti, D., & Presta, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1085 · Cited by 126
Birchenall-Roberts, M. C., Ruscetti, F. W., Kasper, J. J., Lee, H.-D., Friedman, R. D., Geiser, A. G., Sporn, M. B., Roberts, A. B., & Kim, S. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4978-4983.1990 · Cited by 124
Bidder, M., Shao, J.-S., Charlton-Kachigian, N., Loewy, A. P., Semenkovich, C. F., & Towler, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206235200 · Cited by 123
Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors*
Khan, S. A., Lopez‐Chua, C. A., Zhang, J., Fisher, L. W., Sørensen, E. S., & Denhardt, D. T. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10170 · Cited by 121
Osteopontin Deficiency Reduces Experimental Tumor Cell Metastasis to Bone and Soft Tissues
Nemoto, H., Rittling, S. R., Yoshitake, H., Furuya, K., Amagasa, T., Tsuji, K., Nifuji, A., Denhardt, D. T., & Noda, M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.4.652 · Cited by 119
Chellaiah, M., & Hruska, K. A. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.5.743 · Cited by 118
Craig, A. M., Bowden, G. T., Chambers, A. F., Spearman, M. A., Greenberg, A. H., Wright, J., McLeod, M. R., & Denhardt, D. T. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460124 · Cited by 118
Denhardt, D., Mistretta, D., Chambers, A., Krishna, S., Porter, J., Raghuram, S., & Rittling, S. (2004) · Clinical and Experimental Metastasis · doi:10.1023/a:1022550721404 · Cited by 115
Small Integrin Binding Ligand N -Linked Glycoprotein Gene Family Expression in Different Cancers
Fisher, L. W., Jain, A., Tayback, M., & Fedarko, N. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1072 · Cited by 114
Reisman, D., & Rotter, V. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.2.345 · Cited by 111
Cui, J., Zhou, X., Liu, Y., Tang, Z., & Romeih, M. H. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02973.x · Cited by 109
Senger, D. R., Asch, B. B., Smith, B. D., Perruzzi, C. A., & Dvorak, H. F. (1983) · Nature · doi:10.1038/302714a0 · Cited by 108
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival
Wu, C., Wu, M., Chiang, E. I., Wu, C., Chen, Y., Chen, C., Chi, N.-H., Chen, G.-H., & Lin, J. (2006) · Gut · doi:10.1136/gut.2006.109868 · Cited by 108
Agonist-activated αvμ3 on Platelets and Lymphocytes Binds to the Matrix Protein Osteopontin
BENNETT, J. S., Chan, C., Vilaire, G., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8137 · Cited by 107
Angiogenic activity of osteopontin-derived peptide SVVYGLR
Hamada, Y., Nokihara, K., Okazaki, M., Fujitani, W., Matsumoto, T., Matsuo, M., Umakoshi, Y., Takahashi, J., & Matsuura∥, N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.001 · Cited by 106
Structural Requirements for α9β1-Mediated Adhesion and Migration to Thrombin-Cleaved Osteopontin
Smith, L. L., & Giachelli, C. M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4108 · Cited by 105
Denhardt, D. T., & Chambers, A. F. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560109 · Cited by 103
Urquidi, V., Sloan, D. D., Kawai, K., Agarwal, D., Woodman, A., Tarin, D., & Goodison, S. (2002) · PubMed · Cited by 102
Zohar, R., Cheifetz, S., McCulloch, C. A. G., & Sodek, J. (1998) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.1998.tb02206.x · Cited by 98
Hirama, M., Takahashi, F., Takahashi, K., Akutagawa, S., Shimizu, K., Soma, S., Shimanuki, Y., Nishio, K., & Fukuchi, Y. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00286-6 · Cited by 97
Lin, Y.-H., Huang, C., Chao, J.-R., Chen, S., Lee, S.-F., Yen, J. J.-Y., & Yang‐Yen, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2734-2742.2000 · Cited by 96
Guo, X., Zhang, Y. P., Mitchell, D. A., Denhardt, D. T., & Chambers, A. F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.476 · Cited by 95
Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
Wu, Y., Denhardt, D. T., & Rittling, S. R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1200 · Cited by 93
Furger, K. A., Allan, A. L., Wilson, S. M., Hota, C., Vantyghem, S. A., Postenka, C. O., Al‐Katib, W., Chambers, A. F., & Tuck, A. B. (2003) · PubMed · Cited by 92
Hoxa-9 Represses Transforming Growth Factor-β-induced Osteopontin Gene Transcription
Shi, X., Bai, S., Li, L., & Cao, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005955200 · Cited by 88
Medrano, E. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206452 · Cited by 86
Osteopontin induces angiogenesis of murine neuroblastoma cells in mice
Takahashi, F., Akutagawa, S., Fukumoto, H., Tsukiyama, S., Ohe, Y., Takahashi, K., Fukuchi, Y., Saijo, N., & Nishio, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10261 · Cited by 85
Jain, S., Chakraborty, G., & Kundu, G. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0661 · Cited by 83
Chang, Y. S., Kim, H. J., Chang, J., Ahn, C. M., Kim, S. K., & Kim, S. K. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.04.005 · Cited by 83
TGFβ and BMP-2 Activation of the OPN Promoter: Roles of Smad- and Hox-Binding Elements
Hullinger, T. G., Pan, Q., Viswanathan, H. L., & Somerman, M. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5074 · Cited by 82
Osteopontin and colon cancer progression
Yeatman, T. J., & Chambers, A. F. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022502805474 · Cited by 80
Wai, P. Y., Mi, Z., Gao, C., Guo, H., Marroquin, C. E., & Kuo, P. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511962200 · Cited by 80
Self-citationA Regulated Interaction between α5β1 Integrin and Osteopontin
Barry, S. T., Ludbrook, S. B., Murrison, E., & Horgan, C. M. T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2032 · Cited by 80
APC, β-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer
Bright-Thomas, R., & Hargest, R. (2003) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1331 · Cited by 79
Helluin, O., Chan, C., Vilaire, G., Mousa, S. A., DeGrado, W. F., & BENNETT, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001529200 · Cited by 79
Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells
Gao, C., Guo, H., Downey, L., Marroquin, C., Wei, J., & Kuo, P. C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg139 · Cited by 78
Self-citationFeng, B., Rollo, E. E., & Denhardt, D. T. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00118184 · Cited by 74
Osteopontin: An intrinsic inhibitor of inflammation in cartilage
Attur, M. G., Dave, M. N., Stuchin, S. A., Kowalski, A. J., Steiner, G. C., Abramson, S. B., Denhardt, D. T., & Amin, A. R. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<578::aid-anr106>3.0.co;2-7 · Cited by 74
Asosingh, K., Günthert, U., Bakkus, M. H. C., Raeve, H. D., Goes, E., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2000) · PubMed · doi:10.5451/unibas-ep6481 · Cited by 74
Johnson, R. J., GORDON, K. L., Giachelli, C. M., Kurth, T., Skelton, M. M., & Cowley, A. W. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018100-00019 · Cited by 71
Gene Regulation by Tyrosine Kinases: src Protein Activates Various Promoters, Including c- fos
Fujii, M., Shalloway, D. I., & Verma, I. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2493-2499.1989 · Cited by 69
Zhang, Q., Wrana, J. L., & Sodek, J. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17092.x · Cited by 67
Birchenall-Roberts, M. C., Ruscetti, F. W., Kasper, J. J., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4978 · Cited by 67
Jaiswal, A. S., & Narayan, S. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010501)81:2<262::aid-jcb1041>3.0.co;2-r · Cited by 66
Cheifetz, S., LI, I. W. S., Mcculloch, C. A. G., Sampath, K. T., & Sodek, J. (1996) · Connective Tissue Research · doi:10.3109/03008209609029176 · Cited by 63
Adwan, H., Bäuerle, T., & Berger, M. R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700659 · Cited by 61
Mi, Z., Oliver, T., Guo, H., Gao, C., & Kuo, P. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4066 · Cited by 60
Self-citationEl‐Tanani, M., Barraclough, R., Wilkinson, M. C., & Rudland, P. S. (2002) · International Conference on Osteopontin and SIBLING Proteins · doi:10.1100/tsw.2002.238 · Cited by 59
Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue
Scott, J. A., Weir, M. L., Wilson, S. M., Xuan, J. W., Chambers, A. F., & McCormack, D. G. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.6.h2258 · Cited by 55
Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation
Wai, P. Y., Guo, L., Gao, C., Mi, Z., Guo, H., & Kuo, P. C. (2006) · Surgery · doi:10.1016/j.surg.2006.02.005 · Cited by 53
Self-citationIdentification of the Osteopontin gene as a direct target of TP53
Morimoto, I., Sasaki, Y., Ishida, S., Imai, K., & Tokino, T. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10020 · Cited by 53
Wrana, J. L., Kubota, T., Zhang, Q., Overall, C. M., Aubin, J. E., Butler, W. T., & Sodek, J. (1991) · Biochemical Journal · doi:10.1042/bj2730523 · Cited by 48
AP-1 Is Involved in UTP-Induced Osteopontin Expression in Arterial Smooth Muscle Cells
Renault, M., Jalvy, S., Belloc, I., Pasquet, S., Sena, S., Olive, M., Desgranges, C., & Gadeau, A. (2003) · Circulation Research · doi:10.1161/01.res.0000094747.05021.62 · Cited by 43
Gao, C., Guo, H., Mi, Z., Wai, P. Y., & Kuo, P. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.523 · Cited by 41
Self-citationRabinowich, H., Lin, W., Amoscato, A. A., Herberman, R. B., & Whiteside, T. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1124 · Cited by 38
Osteopontin expression, tubulointerstitial disease, and essential hypertension
THOMAS, S., Lombardi, D. M., Giachelli, C. M., Bohle, A., & Johnson, R. E. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00091-0 · Cited by 27
Restoration of CD44H Expression in Colon Carcinomas Reduces Tumorigenicity
Tanabe, K. K., Stamenkovic, I., Cutler, M., & Takahashi, K. (1995) · Annals of Surgery · doi:10.1097/00000658-199510000-00007 · Cited by 25
Blobel, G. A., & Hanafusa, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1162 · Cited by 25
Takahashi, K., Takahashi, F., Hirama, M., Tanabe, K. K., & Fukuchi, Y. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00224-1 · Cited by 25
Chang, P., Tucker, M. A., Hicks, P. H., & Prince, C. W. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00035-3 · Cited by 24
Okadaic acid stimulates osteopontin expression through de novo induction of AP‐1
Kim, H., Lee, M., Kim, H., Shin, H., Choi, J., & Ryoo, H. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10280 · Cited by 23
Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages
Gao, C., Guo, H., Wei, J.-P., & Kuo, P. C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01534-1 · Cited by 20
Self-citationAsaumi, S., Takemoto, M., Yokote, K., Ridall, A. L., Butler, W. T., Fujimoto, M., Kobayashi, K., Kawamura, H., Take, A., Saitō, Y., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00189-7 · Cited by 20
Cited by
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3023 · Cited by 1,112
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Immune microenvironment of gliomas
Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D., & Kaminska, B. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.19 · Cited by 538
Metadata
- Authors
- Wai, P. Y., & Kuo, P. C.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2007-11-30
- Volume
- 27
- Issue
- 1
- Pages
- 103-118
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2083113175
- Cited by
- 321
- References
- 191
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.